{"id":"https://openalex.org/W4399298754","doi":"https://doi.org/10.1158/1078-0432.25956635.v1","title":"Supplementary Figure S6 from Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy","display_name":"Supplementary Figure S6 from Maintenance Pembrolizumab Therapy in Patients with Metastatic HER2-negative Breast Cancer with Prior Response to Chemotherapy","publication_year":2024,"publication_date":"2024-06-03","ids":{"openalex":"https://openalex.org/W4399298754","doi":"https://doi.org/10.1158/1078-0432.25956635.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.25956635.v1","doi":"https://doi.org/10.1158/1078-0432.25956635.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.25956635.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.25956635.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018426062","display_name":"Toshiaki Iwase","orcid":"https://orcid.org/0000-0002-5302-2292","observed_orcids":["https://orcid.org/0000-0002-5302-2292"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Toshiaki Iwase","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5302-2292","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069614323","display_name":"Evan N. Cohen","orcid":"https://orcid.org/0000-0003-4192-9644","observed_orcids":["https://orcid.org/0000-0003-4192-9644"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evan N. Cohen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4192-9644","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028486986","display_name":"Hui Gao","orcid":"https://orcid.org/0000-0003-3918-2342","observed_orcids":["https://orcid.org/0000-0003-3918-2342"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hui Gao","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3918-2342","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070852357","display_name":"Angela Alexander","orcid":"https://orcid.org/0000-0002-6649-7991","observed_orcids":["https://orcid.org/0000-0002-6649-7991"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angela Alexander","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6649-7991","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031867067","display_name":"Megumi Kai","orcid":"https://orcid.org/0000-0002-2270-8793","observed_orcids":["https://orcid.org/0000-0002-2270-8793"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Megumi Kai","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2270-8793","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091164615","display_name":"Vivian Chiv","orcid":"https://orcid.org/0009-0004-1540-3598","observed_orcids":["https://orcid.org/0009-0004-1540-3598"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vivian Chiv","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-1540-3598","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100459932","display_name":"Xiaoping Wang","orcid":"https://orcid.org/0000-0003-4511-8638","observed_orcids":["https://orcid.org/0000-0003-4511-8638"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaoping Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4511-8638","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027464426","display_name":"Savitri Krishnamurthy","orcid":"https://orcid.org/0000-0001-9030-4136","observed_orcids":["https://orcid.org/0000-0001-9030-4136"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Savitri Krishnamurthy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9030-4136","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080439835","display_name":"Diane D. Liu","orcid":"https://orcid.org/0000-0003-3301-0259","observed_orcids":["https://orcid.org/0000-0003-3301-0259"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diane Liu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3301-0259","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014176442","display_name":"Yu Shen","orcid":"https://orcid.org/0000-0002-3899-7868","observed_orcids":["https://orcid.org/0000-0002-3899-7868"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu Shen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3899-7868","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025607663","display_name":"Kumiko Kida","orcid":"https://orcid.org/0000-0002-0946-5053","observed_orcids":["https://orcid.org/0000-0002-0946-5053"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kumiko Kida","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0946-5053","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088889988","display_name":"Alexandre Reuben","orcid":"https://orcid.org/0000-0003-4510-0382","observed_orcids":["https://orcid.org/0000-0003-4510-0382"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexandre Reuben","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4510-0382","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064168158","display_name":"Rachel M. Layman","orcid":"https://orcid.org/0000-0002-8663-0331","observed_orcids":["https://orcid.org/0000-0002-8663-0331"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel M. Layman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8663-0331","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032187437","display_name":"David Luis Ramirez","orcid":"https://orcid.org/0000-0003-2992-6803","observed_orcids":["https://orcid.org/0000-0003-2992-6803"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David L. Ramirez","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2992-6803","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110083321","display_name":"Debu Tripathy","orcid":"https://orcid.org/0000-0002-5711-2404","observed_orcids":["https://orcid.org/0000-0002-5711-2404"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Debasish Tripathy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5711-2404","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042271475","display_name":"Stacy L. Moulder","orcid":"https://orcid.org/0009-0004-6078-2769","observed_orcids":["https://orcid.org/0009-0004-6078-2769"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stacy L. Moulder","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-6078-2769","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053119598","display_name":"Clinton Yam","orcid":"https://orcid.org/0000-0002-0809-0851","observed_orcids":["https://orcid.org/0000-0002-0809-0851"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clinton Yam","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0809-0851","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080832682","display_name":"Vicente Valero","orcid":"https://orcid.org/0000-0001-5913-7480","observed_orcids":["https://orcid.org/0000-0001-5913-7480"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vicente Valero","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5913-7480","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053893309","display_name":"Bora Lim","orcid":"https://orcid.org/0000-0002-4182-6058","observed_orcids":["https://orcid.org/0000-0002-4182-6058"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bora Lim","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4182-6058","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040423978","display_name":"James Mwikya Reuben","orcid":"https://orcid.org/0000-0001-8972-2103","observed_orcids":["https://orcid.org/0000-0001-8972-2103"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James M. Reuben","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8972-2103","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5088814426","display_name":"Naoto Tada Ueno","orcid":"https://orcid.org/0000-0002-0166-7275","observed_orcids":["https://orcid.org/0000-0002-0166-7275"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naoto T. Ueno","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0166-7275","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9520999789237976,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9520999789237976,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.027699999511241913,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.013899999670684338,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9909999966621399},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.8019999861717224},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.9359999895095825},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9940000176429749},{"id":"https://openalex.org/keywords/pd-l1-negative-tumors","display_name":"PD-L1-negative tumors","score":0.8080000281333923},{"id":"https://openalex.org/keywords/tumor-clonality","display_name":"tumor clonality","score":0.8709999918937683},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9520000219345093},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9279999732971191},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.5879999995231628}],"concepts":[{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.8592022657394409},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6669460535049438},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6494694352149963},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.642575740814209},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6394036412239075},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6068480014801025},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5558527112007141},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4908321499824524},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.4364170432090759},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.1247597336769104}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.25956635.v1","doi":"https://doi.org/10.1158/1078-0432.25956635.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.25956635.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.25956635.v1","doi":"https://doi.org/10.1158/1078-0432.25956635.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.25956635.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.699999988079071}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4391375266","https://openalex.org/W2585407512","https://openalex.org/W3037068108","https://openalex.org/W2059423835","https://openalex.org/W2945780494","https://openalex.org/W3041652591","https://openalex.org/W2517747645","https://openalex.org/W2796582438","https://openalex.org/W3180083804","https://openalex.org/W1530841853"],"abstract_inverted_index":{"Supplementary":[0],"Figure":[1],"6.":[2],"Progression-free":[3],"survival":[4,7],"and":[5],"overall":[6],"stratified":[8],"by":[9],"clonality":[10],"in":[11],"patients":[12],"with":[13],"PD-L1\u2013negative":[14],"tumors":[15],"per":[16],"IHC":[17],"analysis":[18],"(N":[19],"=":[20],"32).":[21]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}